Drug Profile
Lidocaine/dextromethorphan - Endo/Indevus
Alternative Names: LidodexNSLatest Information Update: 19 Sep 2003
Price :
$50
*
At a glance
- Originator Endo Pharmaceuticals; Indevus Pharmaceuticals
- Class Antimigraines; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action NMDA receptor antagonists; Opioid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 19 Sep 2003 Discontinued - Preclinical for Migraine in USA (Intranasal)
- 15 May 2002 Interneuron Pharmaceuticals is now called Indevus Pharmaceuticals
- 31 Dec 2001 Endo has been merged with and into Endo Pharmaceuticals